This isn’t about managing the AIDS pandemic. It’s about ending it — and letting a new generation grow and thrive free of its threat.
Lenacapavir, developed by Gilead Sciences, is a twice-yearly injectable for HIV prevention.
We stand at the edge of an extraordinary possibility: to end the AIDS pandemic, eliminating HIV as a public heath threat. Over the last few decades, more than 40 million people have died of AIDS and there are another 39 million people living with…
Continue Reading
News Source: www.forbes.com

Leave a Reply